INTRODUCTION
Lysosomal a-glucosidase (EC 3.2.1.3) is a glycoprotein like the other acid hydrolases that perform their function in the lysosomes. The function of a-glucosidase is degradation of glycogen to glucose. Enzyme deficiency leads to glycogenosis type II, an inherited glycogen-storage disorder (Hers, 1963) . Several patients have been described with a defect in the synthesis or post-translational processing of lysosomal a-glucosidase (Reuser and Kroos, 1982; Beratis et al., 1983; Reuser et al., 1985 Reuser et al., , 1987 Martiniuk et al., 1986 Martiniuk et al., , 1990a ; Van der Ploeg et al., 1989; Hermans et al., 1991a; Zhong et al., 1991) .
During translation, lysosomal enzymes enter the endoplasmic reticulum where glycosylation is assumed to start even before the protein is completely folded (Rothman et al., 1978) . Asparagine residues in the sequence Asn-Xaa-Ser/Thr (Xaa all but Pro) are the potential sites for attachment of N-linked carbohydrate side chains which are transferred en bloc from dolichol pyrophosphate (Marshall, 1972; Kornfeld and Kornfeld, 1985) . However, not all potential glycosylation sites are used. Studies by Bause and Legler (1981) indicate that a proper protein conformation is required for recognition and glycosylation ofa site. After removal of the three terminal glucose residues of the oligosaccharide precursor chain in the endoplasmic reticulum (Kornfeld et al., 1978; Hubbard and Robbins, 1979) , most lysosomal enzymes obtain a mannose 6-phosphate recognition marker as lysosomal targeting signal (Creek and Sly, 1984) . This is accomplished by the transfer of N-acetylglucosamine 1-phosphate from UDP-Nacetylglucosamine to particular mannose residues (Reitman and Kornfeld, 1981; Waheed et al., 1981) , and the subsequent uncovering of the phosphate by a phosphodiesterase which is probably localized in the mid-Golgi (Lazzarino and Gabel, 1988) . Transport to the lysosomes continues via the trans-Golgi cisternae to the trans-Golgi reticulum. Binding to the mannose 6-phosphate receptor in this part of the transport pathway is essential for lysosomal targeting. Lysosomal enzymes are then Evidence is presented that at least two of the oligosaccharide side chains of human lysosomal a-glucosidase are phosphorylated. Elimination of six of the seven sites does not disturb enzyme synthesis or function. However, removal of the second glycosylation site at Asn-233 interferes dramatically with the formation of mature enzyme. The mutant precursor is synthesized normally and assembles in the endoplasmic reticulum, but immunoelectron microscopy reveals a deficiency of a-glucosidase in the Golgi complex and in the more distal compartments of the lysosomal transport pathway.
transported to the late endosomes (Griffiths and Simons, 1986) , where a fall in pH causes the ligand to dissociate from the receptor. The enzymes continue their way to the lysosomes and the receptor cycles back to the Golgi complex (Brown et al., 1986; Von Figura and Hasilik, 1986) .
Lysosomal a-glucosidase is known to follow this transport route and is subject to several post-translational modifications involving both the carbohydrate chains and the protein backbone. The enzyme is synthesized as a glycosylated precursor of approximately 110 kDa, which is phosphorylated. The amino acid sequence of lysosomal a-glucosidase, as derived from the cloned cDNA, indicates that there are seven potential glycosylation sites (Hoefsloot et al., 1988; Martiniuk et al., 1990b) . Proteolytic processing gives rise to a 95 kDa intermediate form and results finally in the formation of two lysosomal enzyme species of 76 kDa and 70 kDa (Hasilik and Neufeld, 1980; Reuser et al., 1985) . The latter two forms of lysosomal aglucosidase have been purified and analysed with respect to their sugar content and carbohydrate chain structure. It was estimated that lysosomal a-glucosidase from human placenta and liver contains an average of four to five carbohydrate chains (Belenky et al., 1979; Mutsaers et al., 1987) .
The aim of this study was to establish the actual number of glycosylation sites and to determine the role of each site in the transport and catalytic function of lysosomal a-glucosidase. The approach that was taken was to eliminate the potential sites by site-directed mutagenesis and to study the effect by expression of the mutant cDNA constructs in vitro and in transiently transfected COS cells.
MATERIALS AND METHODS

Construction of mutants
The Muta-Gene in vitro mutagenesis kit from Bio-Rad (Richmond, CA, U.S.A.) was used to carry out site-directed mutagenesis, as described by Kunkel (1985) . The oligonucleotides (Green et al., 1988) were performed exactly as described previously (Hermans et al., 1991b) .
Transient expression in COS cells
COS-1 cells (Gluzman, 1981) were cultured in Dulbecco's modification of Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS) and antibiotics at 37 'C. The transfection protocol was as described previously (Hoefsloot et al., 1990) . The culture medium was collected and the cells were harvested 90 h after transfection. Cell homogenates were made by repeated freezing and thawing of cell pellets in distilled water.
The activity of lysosomal a-glucosidase in the cell homogenate and the culture medium was measured with 4-methylumbelliferyl a-D-glucopyranoside (4-MU) as described previously (Reuser et al., 1978) . The protein concentrations of cell homogenates were determined with the use of the BCA protein assay kit (Pierce).
Lysosomal a-glucosidase was immunoprecipitated from culture media using a rabbit polyclonal antiserum against human lysosomal a-glucosidase in combination with Staphylococcus aureus membranes (Bethesda Research Laboratories) and analysed by immunoblotting . To characterize the intracellular forms of lysosomal a-glucosidase, COS cells were labelled for 2 h with [3H]leucine (190, uCi/mmol) (Amersham U.K.) 65 h after transfection, and lysosomal aglucosidase was immunoprecipitated either directly (pulse) or after 16 h of chase. The different molecular species of lysosomal a-glucosidase were separated by SDS/PAGE (8 % acrylamide, 1 % cross-link unless indicated otherwise) as described (Reuser et al., 1985) .
Phosphorylation of lysosomal a-glucosidase COS cells were transfected as described above. After 90 h the cells were preincubated for 1 h in phosphate-free DMEM to which FCS, dialysed against 0.9% NaCl, was added in a final concentration of 4 %. The medium was then replaced with fresh medium and carrier-free [32P]PJ (Amersham) was added at a concentration of 80 ,uCi/ml. The cells were pulse-labelled for 6 h and harvested either directly or after a subsequent chase of 12 h. Lysosomal a-glucosidase was immunoprecipitated from cell extracts as described (Reuser et al., 1985) and analysed by SDS/PAGE.
Transcription and translation in vitro
Wild-type and mutant cDNAs cloned in the expression vector pSG5 were linearized with BglII and used as a template in the transcription reaction. The T7 promoter was used for transcription. The reaction was allowed to proceed for 1.5 h at 40°C in 40 mM Tris/HCI, pH 7.5, containing 6 mM MgCl2, 2 mM spermidine, 10 mM NaCl, 10 mM dithiothreitol, 1 unit of RNAase inhibitor (Promega), 0.8 mg/ml BSA, 500 1sM ATP, CTP and UTP, 50 , uM Immunocytochemistry Immunocytochemistry on transiently transfected COS cells was performed exactly as described previously (Hoefsloot et al., 1990) .
RESULTS
In lysosomal a-glucosidase, asparagine residues in the recognition sequence for N-linked glycosylation, Asn-Xaa-Thr/Ser (Xaa can be any residue except Pro), are found at seven positions, namely at Asn-140, -233, -390, -470, -652, -882 and -925 (Hoefsloot et al., 1988; Martiniuk et al., 1990b ) (EMBL entry number Y00839). These potential glycosylation sites were eliminated one by one to determine which sites were actually used, and to examine the importance ofindividual sites for enzyme function and lysosomal targeting. To this end the recognition consensus sequence of (kDa) Figure 1 Translation The use of glycosylation sites was tested by cloning the wild-type and mutant cDNAs in the eukaryotic expression vector pSG5 allowing in vitro transcription and subsequent translation of the mRNAs in the presenoe of dog pancreatic microsomes. Translation of wild-type mRNA resulted in the formation of two molecular species, a trtinslocated and glycosylated precursor of 112 kDa and an unglycosylated precursor of 97 kDa (Figure 1 ; and Van der Horst et al., 1987) . The glycosylation sites are easily identified by this method. Figure 1 , for instance, shows that the substitution of Asn-233 by Gln-233 (AG2) results in a 2 kDa size decrease in the glycosylated precursor, whereas the apparent size of the unglycosylated wild-type and mutant precursor remains the same (97 kDa).
Transient expression in COS cells
The functional consequence of the removal of glycosylation sites was investigated by following the synthesis and maturation of aglucosidase in transiently transfected COS cells.
[3H]Leucinelabelled wild-type and mutant lysosomal a-glucosidase species were immunoprecipitated from cell homogenates after a 2 h pulse period or after a subsequent chase of 16 h, and analysed by SDS/PAGE (Figure 2 ). The secreted form of lysosomal atglucosidase was immunoprecipitated from the culture media and analysed by Western blotting (Figure 3 ). In cells transfected with wild-type cDNA the lysosomal a-glucosidase precursor of 110 kDa is synthesized (pulse) and converted into a 95 kDa intermediate and a 76 kDa mature species (chase) (Figure 2 ). The culture medium contains only the secreted 110 kDa precursor ( Figure 3 ). All mutant precursor proteins (isolated from cells and media) missing one potential glycosylation site appeared to have a slightly lower molecular mass (108 kDa) than the wild-type precursor. This indicates that all seven potential glycosylation sites of lysosomal az-glucosidase are used. For the mutants lacking the first, third, fourth or fifth glycosylation site (AGI, AG3, AG4 and AG5), the lower molecular mass is maintained during the maturation process leading to the formation of a 93 kDa processing intermediate and a 74 kDa mature enzyme species (Figure 2 , Chase). A different effect was observed with the mutants AG6 and AG7. The precursor and the processing intermediate were smaller (93 kDa) than the comparable wildtype species, but the final maturation products of AG6 and AG7 (76 kDa) and wild-type lysosomal a-glucosidase were of the same size (Figure 2 , Chase). This indicates that a C-terminal peptide containing the glycosylation sites at Asn-882 and Asn-925 is cleaved off when lysosomal a-glucosidase matures from 95 to 76 kDa. The only glycosylation site which has a severe effect on the biosynthesis of a-glucosidase when eliminated is Asn-233 ( Figure  2 ). The mutant precursor of 108 kDa is evidently formed during the 2 h pulse, but the 93 kDa processing intermediate and the 74 kDa mature enzyme are clearly deficient in the chase. The AG2 precursor is not secreted into the culture medium, in contrast with all other mutant precursors which are secreted normally (Figure 3) .
To investigate the effect of glycosylation on the catalytic activity of lysosomal a-glucosidase, cell homogenates and culture media of transfected COS cells were assayed for enzyme activity. Table 2 . When compared with wild-type, all glycosylation-site-defective mutants except AG2 exhibited intracellularly a similar activity of lysosomal a-glucosidase. AG2 was different in that only 5 % of wild-type activity was measured in the cell homogenates and less than 3 % in the medium. Nearnormal levels of lysosomal a-glucosidase were secreted by COS cells transfected with the other mutant constructs ( Table 2) .
Phosphorylation of lysosonmal a-glucosidase
To determine which of the seven oligosaccharide chains of lysosomal a-glucosidase were phosphorylated, we transfected COS cells with the wild-type and mutant cDNA constructs and 
Intracellular transport
The intracellular localization of the mutant a-glucosidase species missing one glycosylation site was investigated using immunocytochemistry. As observed in earlier studies, the formation of mature enzyme was in all instances correlated with a typical punctate lysosomal labelling pattern. Figure 5 (a), for instance, illustrates the lysosomal localization of AG4.
Transfection of COS cells with AG2, showing an apparent maturation defect, resulted in a diffuse network of labelled structures spreading from the nucleus into the cytoplasm ( Figure  5b ). The exact intracellular localization of AG2 was revealed by immunoelectron microscopy ( Figure 6 ). Labelling of the nuclear envelope and the endoplasmic reticulum was obtained but the enzyme could not be detected in the Golgi complex nor in the trans-Golgi reticulum or the lysosomes. The latter compartments were labelled after transfection with the wild-type cDNA construct (results not shown). (Gieselman et al., 1989) . However, the introduction of this mutation into wild-type cDNA did not affect the catalytic function or the stability of the encoded enzyme. The decreased arylsulphatase A activity leading to this pseudodeficiency is caused by a mutation abolishing the first polyadenylation signal. As a consequence, the mRNA species is labile which explains the severely diminished rate of enzyme synthesis (Gieselman et al., 1989) . The second mutation of a glycosylation site was found in saposin B. The mutation changes to Ile which eliminates the only possible site. The mutant protein is believed to be rapidly degraded (Rafi et al., 1990; Kretz et al., 1990 Furthermore, it is evident that at least one ofthe five carbohydrate chains located within the boundaries of the 76 kDa polypeptide is phosphorylated, since the mature enzyme is also phosphatelabelled. The maturation defect of mutant AG2 prevents the assessment of phosphorylation at site Asn-233 and thereby hampers a more detailed analysis of the phosphorylation sites by site-directed mutagenesis. Further identification of the phosphorylation sites via sequence analysis of phosphorylated peptides is in progress.
